Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna MRNA revealed 13 unusual trades.
Delving into the details, we found 53% of traders were bullish, while 46% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $131,905, and 9 were calls, valued at $371,568.
Predicted Price Range
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $40.0 to $115.0 for Moderna over the recent three months.
Insights into Volume & Open Interest
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale trades within a strike price range from $40.0 to $115.0 in the last 30 days.
Moderna Call and Put Volume: 30-Day Overview
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| MRNA | CALL | SWEEP | BULLISH | 03/15/24 | $110.00 | $67.2K | 1.7K | 434 |
| MRNA | CALL | TRADE | BULLISH | 04/05/24 | $100.00 | $62.0K | 256 | 148 |
| MRNA | PUT | SWEEP | BULLISH | 07/19/24 | $95.00 | $43.6K | 847 | 67 |
| MRNA | CALL | TRADE | BEARISH | 04/19/24 | $105.00 | $40.3K | 2.4K | 230 |
| MRNA | CALL | SWEEP | BEARISH | 03/15/24 | $98.00 | $38.4K | 844 | 124 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Following our analysis of the options activities associated with Moderna, we pivot to a closer look at the company's own performance.
Present Market Standing of Moderna
- Trading volume stands at 2,962,331, with MRNA's price down by 0.0%, positioned at $99.48.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 55 days.
What The Experts Say On Moderna
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $100.66666666666667.
- An analyst from Canaccord Genuity has decided to maintain their Hold rating on Moderna, which currently sits at a price target of $91.
- An analyst from HSBC has revised its rating downward to Reduce, adjusting the price target to $86.
- In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $125.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
